Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 39
Filtrer
1.
Toxins (Basel) ; 15(5)2023 05 12.
Article de Anglais | MEDLINE | ID: mdl-37235366

RÉSUMÉ

Some 14% of global prevalence, based on high-income country populations, suffers from migraine. Chronic migraine is very disabling, being characterized by at least 15 headache days per month of which at least 8 days present the features of migraine. Onabotulinumtoxin A, targeting the machinery for exocytosis of neurotransmitters and neuropeptides, has been approved for use in chronic migraine since 2010. This systematic review and meta-analysis appraises the safety of onabotulinumtoxin A treatment for chronic migraine and the occurrence of treatment-related adverse events (TRAEs) in randomized, clinical studies in comparison with placebo or other comparators and preventative treatments according to the most updated Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 recommendations. The search retrieved 888 total records. Nine studies are included and seven were eligible for meta-analysis. The present study demonstrates that toxin produces more TRAEs than placebo, but less than oral topiramate, supporting the safety of onabotulinumtoxin A, and highlights the heterogeneity of the studies present in the literature (I2 = 96%; p < 0.00001). This points to the need for further, adequately powered, randomized clinical trials assessing the safety of onabotulinumtoxin A in combination with the newest treatment options.


Sujet(s)
Toxines botuliniques de type A , Migraines , Humains , Toxines botuliniques de type A/effets indésirables , Essais contrôlés randomisés comme sujet , Migraines/traitement médicamenteux , Céphalée/traitement médicamenteux
2.
Int J Mol Sci ; 24(2)2023 Jan 10.
Article de Anglais | MEDLINE | ID: mdl-36674850

RÉSUMÉ

The trafficking of transient receptor potential (TRP) channels to the plasma membrane and the release of calcitonin gene-related peptide (CGRP) from trigeminal ganglion neurons (TGNs) are implicated in some aspects of chronic migraines. These exocytotic processes are inhibited by cleavage of SNAREs with botulinum neurotoxins (BoNTs); moreover, type A toxin (/A) clinically reduces the frequency and severity of migraine attacks but not in all patients for unknown reasons. Herein, neonatal rat TGNs were stimulated with allyl isothiocyanate (AITC), a TRPA1 agonist, and dose relationships were established to link the resultant exocytosis of CGRP with Ca2+ influx. The CGRP release, quantified by ELISA, was best fit by a two-site model (EC50 of 6 and 93 µM) that correlates with elevations in intracellular Ca2+ [Ca2+]i revealed by time-lapse confocal microscopy of fluo-4-acetoxymethyl ester (Fluo-4 AM) loaded cells. These signals were all blocked by two TRPA1 antagonists, HC-030031 and A967079. At low [AITC], [Ca2+]i was limited because of desensitisation to the agonist but rose for concentrations > 0.1 mM due to a deduced non-desensitising second phase of Ca2+ influx. A recombinant BoNT chimera (/DA), which cleaves VAMP1/2/3, inhibited AITC-elicited CGRP release to a greater extent than SNAP-25-cleaving BoNT/A. /DA also proved more efficacious against CGRP efflux evoked by a TRPV1 agonist, capsaicin. Nerve growth factor (NGF), a pain-inducing sensitiser of TGNs, enhanced the CGRP exocytosis induced by low [AITC] only. Both toxins blocked NGF-induced neuropeptide secretion and its enhancement of the response to AITC. In conclusion, NGF sensitisation of sensory neurons involves TRPA1, elevated Ca2+ influx, and CGRP exocytosis, mediated by VAMP1/2/3 and SNAP-25 which can be attenuated by the BoNTs.


Sujet(s)
Toxines botuliniques , Canaux cationiques TRP , Rats , Animaux , Peptide relié au gène de la calcitonine/pharmacologie , Peptide relié au gène de la calcitonine/métabolisme , Synaptobrévine-1/métabolisme , Facteur de croissance nerveuse/pharmacologie , Facteur de croissance nerveuse/métabolisme , Toxines botuliniques/métabolisme , Cellules réceptrices sensorielles/métabolisme , Canaux cationiques TRP/métabolisme , Membre-1 de la sous-famille A de canaux cationiques à potentiel de récepteur transitoire/métabolisme
3.
Toxins (Basel) ; 14(2)2022 02 04.
Article de Anglais | MEDLINE | ID: mdl-35202143

RÉSUMÉ

Chimeras of botulinum neurotoxin (BoNT) serotype A (/A) combined with /E protease might possess improved analgesic properties relative to either parent, due to inheriting the sensory neurotropism of the former with more extensive disabling of SNAP-25 from the latter. Hence, fusions of /E protease light chain (LC) to whole BoNT/A (LC/E-BoNT/A), and of the LC plus translocation domain (HN) of /E with the neuronal acceptor binding moiety (HC) of /A (BoNT/EA), created previously by gene recombination and expression in E. coli., were used. LC/E-BoNT/A (75 units/kg) injected into the whisker pad of rats seemed devoid of systemic toxicity, as reflected by an absence of weight loss, but inhibited the nocifensive behavior (grooming, freezing, and reduced mobility) induced by activating TRPV1 with capsaicin, injected at various days thereafter. No sex-related differences were observed. c-Fos expression was increased five-fold in the trigeminal nucleus caudalis ipsi-lateral to capsaicin injection, relative to the contra-lateral side and vehicle-treated controls, and this increase was virtually prevented by LC/E-BoNT/A. In vitro, LC/E-BoNT/A or /EA diminished CGRP exocytosis from rat neonate trigeminal ganglionic neurons stimulated with up to 1 µM capsaicin, whereas BoNT/A only substantially reduced the release in response to 0.1 µM or less of the stimulant, in accordance with the /E protease being known to prevent fusion of exocytotic vesicles.


Sujet(s)
Analgésiques/pharmacologie , Toxines botuliniques de type A/pharmacologie , Capsaïcine/pharmacologie , Neurotoxines/pharmacologie , Cellules réceptrices sensorielles/effets des médicaments et des substances chimiques , Animaux , Animaux nouveau-nés , Comportement animal/effets des médicaments et des substances chimiques , Peptide relié au gène de la calcitonine/métabolisme , Femelle , Mâle , Douleur/induit chimiquement , Douleur/traitement médicamenteux , Douleur/métabolisme , Rat Sprague-Dawley , Cellules réceptrices sensorielles/métabolisme , Protéine SNAP-25/métabolisme , Ganglion trigéminal/cytologie
4.
Int J Mol Sci ; 23(2)2022 Jan 14.
Article de Anglais | MEDLINE | ID: mdl-35055082

RÉSUMÉ

Nerve growth factor (NGF) is known to intensify pain in various ways, so perturbing pertinent effects without negating its essential influences on neuronal functions could help the search for much-needed analgesics. Towards this goal, cultured neurons from neonatal rat trigeminal ganglia-a locus for craniofacial sensory nerves-were used to examine how NGF affects the Ca2+-dependent release of a pain mediator, calcitonin gene-related peptide (CGRP), that is triggered by activating a key signal transducer, transient receptor potential vanilloid 1 (TRPV1) with capsaicin (CAP). Measurements utilised neurons fed with or deprived of NGF for 2 days. Acute re-introduction of NGF induced Ca2+-dependent CGRP exocytosis that was inhibited by botulinum neurotoxin type A (BoNT/A) or a chimera of/E and/A (/EA), which truncated SNAP-25 (synaptosomal-associated protein with Mr = 25 k) at distinct sites. NGF additionally caused a Ca2+-independent enhancement of the neuropeptide release evoked by low concentrations (<100 nM) of CAP, but only marginally increased the peak response to ≥100 nM. Notably, BoNT/A inhibited CGRP exocytosis evoked by low but not high CAP concentrations, whereas/EA effectively reduced responses up to 1 µM CAP and inhibited to a greater extent its enhancement by NGF. In addition to establishing that sensitisation of sensory neurons to CAP by NGF is dependent on SNARE-mediated membrane fusion, insights were gleaned into the differential ability of two regions in the C-terminus of SNAP-25 (181-197 and 198-206) to support CAP-evoked Ca2+-dependent exocytosis at different intensities of stimulation.


Sujet(s)
Peptide relié au gène de la calcitonine/biosynthèse , Capsaïcine/pharmacologie , Facteur de croissance nerveuse/métabolisme , Cellules réceptrices sensorielles/effets des médicaments et des substances chimiques , Cellules réceptrices sensorielles/métabolisme , Ganglion trigéminal/effets des médicaments et des substances chimiques , Ganglion trigéminal/métabolisme , Animaux , Toxines botuliniques de type A/pharmacologie , Calcium/métabolisme , Signalisation calcique/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Exocytose/effets des médicaments et des substances chimiques , Facteur de croissance nerveuse/pharmacologie , Protéolyse , Rats , Protéine SNAP-25/métabolisme
5.
Plant Dis ; 106(8): 2228-2238, 2022 Aug.
Article de Anglais | MEDLINE | ID: mdl-34978874

RÉSUMÉ

Meta-analysis was used to compare yield protection and nematode suppression provided by two seed-applied and two soil-applied nematicides against Meloidogyne incognita and Rotylenchulus reniformis on cotton across 3 years and several trial locations in the U.S. Cotton Belt. Nematicides consisted of thiodicarb- and fluopyram-treated seed, aldicarb and fluopyram applied in furrow, and combinations of the seed treatments and soil-applied fluopyram. The nematicides had no effect on nematode reproduction or root infection but had a significant impact on seed cotton yield response ([Formula: see text]), with an average increase of 176 and 197 kg/ha relative to the nontreated control in M. incognita and R. reniformis infested fields, respectively. However, because of significant variation in yield protection and nematode suppression by nematicides, five or six moderator variables (cultivar resistance [M. incognita only], nematode infestation level, nematicide treatment, application method, trial location, and growing season) were used depending on nematode species. In M. incognita-infested fields, greater yield protection was observed with nematicides applied in furrow and with seed-applied + in-furrow than with solo seed-applied nematicide applications. Most notable of these in-furrow nematicides were aldicarb and fluopyram (>131 g/ha) with or without a seed-applied nematicide compared with thiodicarb. In R. reniformis-infested fields, moderator variables provided no further explanation of the variation in yield response produced by nematicides. Furthermore, moderator variables provided little explanation of the variation in nematode suppression by nematicides in M. incognita- and R. reniformis-infested fields. The limited explanation by the moderator variables on the field efficacy of nematicides in M. incognita- and R. reniformis-infested fields demonstrates the difficulty of managing these pathogens with nonfumigant nematicides across the U.S. Cotton Belt.


Sujet(s)
Antihelminthiques antinématodes , Tylenchoidea , Aldicarb/toxicité , Animaux , Antihelminthiques antinématodes/toxicité , Benzamides/toxicité , Gossypium , Pyridines/toxicité , Graines , Sol , Tylenchoidea/effets des médicaments et des substances chimiques , Tylenchoidea/physiologie , États-Unis
6.
Cell Physiol Biochem ; 55(4): 428-448, 2021 Jul 10.
Article de Anglais | MEDLINE | ID: mdl-34242501

RÉSUMÉ

BACKGROUND/AIMS: Nociceptors detect noxious capsaicin (CAPS) via the transient receptor potential vanilloid 1 (TRPV1) ion channel, but coding mechanisms for relaying CAPS concentration [CAPS] remain obscure. Prolonged (up to 1h.) exposure to CAPS is used clinically to desensitise sensory fibres for treatment of neuropathic pain, but its signalling has typically been studied in cultures of dissociated sensory neurons employing low cell numbers and very short exposure times. Thus, it was pertinent to examine responses to longer CAPS exposures in large populations of adult neurons. METHODS: Confocal fluorescence microscopy was used to monitor the simultaneous excitation by CAPS of neuronal populations in intact L3/4 dorsal root ganglia (DRG) explants from adult pirt-GCaMP3 mice that express a cytoplasmic, genetically-encoded Ca2+ sensor in almost all primary sensory neurons. Peak analysis was performed using GraphPad Prism 9 to deconstruct the heterogenous and complex fluorescence signals observed into informative, readily-comparable measurements: number of signals, their lag time, maximum intensity relative to baseline (Max.) and duration. RESULTS: Exposure for 5 min. to CAPS activated plasmalemmal TRPV1 and led to increased fluorescence due to Ca2+ entry into DRG neurons (DRGNs), as it was prevented by capsazepine or removal of extracellular Ca2+. Increasing [CAPS] (0.3, 1 and 10 µM, respectively) evoked signals from more neurons (123, 275 and 390 from 5 DRG) with shorter average lag (6.4 ± 0.4, 3.3 ± 0.2 and 1.9 ± 0.1 min.) and longer duration (1.4 ± 0.2, 2.9 ± 0.2 and 4.8 ± 0.3 min.). Whilst raising [CAPS] produced a modest augmentation of Max. for individual neurons, those with large increases were selectively expedited; this contributed to a faster onset and higher peak of cumulative fluorescence for an enlarged responding neuronal population. CAPS caused many cells to fluctuate between high and low levels of fluorescence, with consecutive pulses increasing Max. and duration especially when exposure was extended from 5 to 20 min. Such signal facilitation counteracted tachyphylaxis, observed upon repeated exposure to 1 µM CAPS, preserving the cumulative fluorescence over time (signal density) in the population. CONCLUSION: Individual neurons within DRG differed extensively in the dynamics of response to CAPS, but systematic changes elicited by elevating [CAPS] increased signal density in a graded manner, unveiling a possible mechanism for population coding of responses to noxious chemicals. Signal density is sustained during prolonged and repeated exposure to CAPS, despite profound tachyphylaxis in some neurons, by signal facilitation in others. This may explain the burning sensation that persists for several hours when CAPS is used clinically.


Sujet(s)
Calcium/métabolisme , Capsaïcine/pharmacologie , Ganglions sensitifs des nerfs spinaux/métabolisme , Nocicepteurs/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Canaux cationiques TRPV/métabolisme , Animaux , Femelle , Ganglions sensitifs des nerfs spinaux/cytologie , Mâle , Souris , Souris transgéniques , Nocicepteurs/cytologie , Transduction du signal/génétique , Canaux cationiques TRPV/génétique
7.
Int J Mol Sci ; 22(5)2021 Mar 04.
Article de Anglais | MEDLINE | ID: mdl-33806699

RÉSUMÉ

Nociceptors sense hazards via plasmalemmal cation channels, including transient receptor potential vanilloid 1 (TRPV1). Nerve growth factor (NGF) sensitises TRPV1 to capsaicin (CAPS), modulates nociceptor excitability and induces thermal hyperalgesia, but cellular mechanisms remain unclear. Confocal microscopy was used to image changes in intracellular Ca2+ concentration ([Ca2+]i) across neuronal populations in dorsal root ganglia (DRG) explants from pirt-GCaMP3 adult mice, which express a fluorescent reporter in their sensory neurons. Raised [Ca2+]i was detected in 84 neurons of three DRG explants exposed to NGF (100 ng/mL) and most (96%) of these were also excited by 1 µM CAPS. NGF elevated [Ca2+]i in about one-third of the neurons stimulated by 1 µM CAPS, whether applied before or after the latter. In neurons excitable by NGF, CAPS-evoked [Ca2+]i signals appeared significantly sooner (e.g., respective lags of 1.0 ± 0.1 and 1.9 ± 0.1 min), were much (>30%) brighter and lasted longer (6.6 ± 0.4 vs. 3.9 ± 0.2 min) relative to those non-responsive to the neurotrophin. CAPS tachyphylaxis lowered signal intensity by ~60% but was largely prevented by NGF. Increasing CAPS from 1 to 10 µM nearly doubled the number of cells activated but only modestly increased the amount co-activated by NGF. In conclusion, a sub-population of the CAPS-sensitive neurons in adult mouse DRG that can be excited by NGF is more sensitive to CAPS, responds with stronger signals and is further sensitised by transient exposure to the neurotrophin.


Sujet(s)
Signalisation calcique/effets des médicaments et des substances chimiques , Calcium/métabolisme , Capsaïcine/pharmacologie , Ganglions sensitifs des nerfs spinaux/effets des médicaments et des substances chimiques , Facteur de croissance nerveuse/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Nociception/effets des médicaments et des substances chimiques , Animaux , Femelle , Ganglions sensitifs des nerfs spinaux/métabolisme , Hyperalgésie/métabolisme , Mâle , Souris , Facteurs de croissance nerveuse/métabolisme , Neurones/métabolisme , Nocicepteurs/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Canaux cationiques TRPV/métabolisme
8.
Front Plant Sci ; 11: 564495, 2020.
Article de Anglais | MEDLINE | ID: mdl-33262774

RÉSUMÉ

The conserved oligomeric Golgi (COG) complex, functioning in retrograde trafficking, is a universal structure present among eukaryotes that maintains the correct Golgi structure and function. The COG complex is composed of eight subunits coalescing into two sub-complexes. COGs1-4 compose Sub-complex A. COGs5-8 compose Sub-complex B. The observation that COG interacts with the syntaxins, suppressors of the erd2-deletion 5 (Sed5p), is noteworthy because Sed5p also interacts with Sec17p [alpha soluble NSF attachment protein (α-SNAP)]. The α-SNAP gene is located within the major Heterodera glycines [soybean cyst nematode (SCN)] resistance locus (rhg1) and functions in resistance. The study presented here provides a functional analysis of the Glycine max COG complex. The analysis has identified two paralogs of each COG gene. Functional transgenic studies demonstrate at least one paralog of each COG gene family functions in G. max during H. glycines resistance. Furthermore, treatment of G. max with the bacterial effector harpin, known to function in effector triggered immunity (ETI), leads to the induced transcription of at least one member of each COG gene family that has a role in H. glycines resistance. In some instances, altered COG gene expression changes the relative transcript abundance of syntaxin 31. These results indicate that the G. max COG complex functions through processes involving ETI leading to H. glycines resistance.

9.
Plant Physiol Biochem ; 137: 25-41, 2019 Apr.
Article de Anglais | MEDLINE | ID: mdl-30711881

RÉSUMÉ

Mitogen activated protein kinases (MAPKs) play important signal transduction roles. However, little is known regarding how they influence the gene expression of other family members and the relationship to a biological process, including the Glycine max defense response to Heterodera glycines. Transcriptomics have identified MAPK gene expression occurring within root cells undergoing a defense response to a pathogenic event initiated by H. glycines in the allotetraploid Glycine max. Functional analyses are presented for its 32 MAPKs revealing 9 have a defense role, including homologs of Arabidopsis thaliana MAPK (MPK) MPK2, MPK3, MPK4, MPK5, MPK6, MPK13, MPK16 and MPK20. Defense signaling occurring through pathogen activated molecular pattern (PAMP) triggered immunity (PTI) and effector triggered immunity (ETI) have been determined in relation to these MAPKs. Five different types of gene expression relate to MAPK expression, influencing PTI and ETI gene expression and proven defense genes including an ABC-G transporter, 20S membrane fusion particle components, glycoside biosynthesis, carbon metabolism, hemicellulose modification, transcription and secretion. The experiments show MAPKs broadly influence defense MAPK gene expression, including the co-regulation of parologous MAPKs and reveal its relationship to proven defense genes. The experiments reveal each defense MAPK induces the expression of a G. max homolog of a PATHOGENESIS RELATED1 (PR1), itself shown to function in defense in the studied pathosystem.


Sujet(s)
Glycine max/parasitologie , Interactions hôte-parasite/physiologie , Mitogen-Activated Protein Kinases/génétique , Protéines végétales/génétique , Tylenchoidea/pathogénicité , Animaux , Régulation de l'expression des gènes végétaux , Système de signalisation des MAP kinases , Mitogen-Activated Protein Kinases/métabolisme , Famille multigénique , Protéines végétales/métabolisme , Racines de plante/génétique , Racines de plante/parasitologie , Végétaux génétiquement modifiés , Interférence par ARN , Glycine max/physiologie
10.
Plant Physiol Biochem ; 129: 331-348, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29936240

RÉSUMÉ

Soybean (Glycine max) infection by the charcoal rot (CR) ascomycete Macrophomina phaseolina is enhanced by the soybean cyst nematode (SCN) Heterodera glycines. We hypothesized that G. max genetic lines impairing infection by M. phaseolina would also limit H. glycines parasitism, leading to resistance. As a part of this M. phaseolina resistance process, the genetic line would express defense genes already proven to impair nematode parasitism. Using G. max[DT97-4290/PI 642055], exhibiting partial resistance to M. phaseolina, experiments show the genetic line also impairs H. glycines parasitism. Furthermore, comparative studies show G. max[DT97-4290/PI 642055] exhibits induced expression of the effector triggered immunity (ETI) gene NON-RACE SPECIFIC DISEASE RESISTANCE 1/HARPIN INDUCED1 (NDR1/HIN1) that functions in defense to H. glycines as compared to the H. glycines and M. phaseolina susceptible line G. max[Williams 82/PI 518671]. Other defense genes that are induced in G. max[DT97-4290/PI 642055] include the pathogen associated molecular pattern (PAMP) triggered immunity (PTI) genes ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1), NONEXPRESSOR OF PR1 (NPR1) and TGA2. These observations link G. max defense processes that impede H. glycines parasitism to also potentially function toward impairing M. phaseolina pathogenicity. Testing this hypothesis, G. max[Williams 82/PI 518671] genetically engineered to experimentally induce GmNDR1-1, EDS1-2, NPR1-2 and TGA2-1 expression leads to impaired M. phaseolina pathogenicity. In contrast, G. max[DT97-4290/PI 642055] engineered to experimentally suppress the expression of GmNDR1-1, EDS1-2, NPR1-2 and TGA2-1 by RNA interference (RNAi) enhances M. phaseolina pathogenicity. The results show components of PTI and ETI impair both nematode and M. phaseolina pathogenicity.


Sujet(s)
Ascomycota , Résistance à la maladie/génétique , Glycine max/microbiologie , Maladies des plantes/microbiologie , Animaux , Expression des gènes , Gènes de plante/génétique , Gènes de plante/physiologie , Nematoda , Maladies des plantes/immunologie , Maladies des plantes/parasitologie , Racines de plante/microbiologie , Tiges de plante/microbiologie , Végétaux génétiquement modifiés , Réaction de polymérisation en chaîne , Glycine max/génétique , Glycine max/immunologie , Glycine max/parasitologie
11.
Plant Physiol Biochem ; 121: 161-175, 2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-29107936

RÉSUMÉ

The bacterial effector harpin induces the transcription of the Arabidopsis thaliana NON-RACE SPECIFIC DISEASE RESISTANCE 1/HARPIN INDUCED1 (NDR1/HIN1) coiled-coil nucleotide binding leucine rich repeat (CC-NB-LRR) defense signaling gene. In Glycine max, Gm-NDR1-1 transcripts have been detected within root cells undergoing a natural resistant reaction to parasitism by the syncytium-forming nematode Heterodera glycines, functioning in the defense response. Expressing Gm-NDR1-1 in Gossypium hirsutum leads to resistance to Meloidogyne incognita parasitism. In experiments presented here, the heterologous expression of Gm-NDR1-1 in G. hirsutum impairs Rotylenchulus reniformis parasitism. These results are consistent with the hypothesis that Gm-NDR1-1 expression functions broadly in generating a defense response. To examine a possible relationship with harpin, G. max plants topically treated with harpin result in induction of the transcription of Gm-NDR1-1. The result indicates the topical treatment of plants with harpin, itself, may lead to impaired nematode parasitism. Topical harpin treatments are shown to impair G. max parasitism by H. glycines, M. incognita and R. reniformis and G. hirsutum parasitism by M. incognita and R. reniformis. How harpin could function in defense has been examined in experiments showing it also induces transcription of G. max homologs of the proven defense genes ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1), TGA2, galactinol synthase, reticuline oxidase, xyloglucan endotransglycosylase/hydrolase, alpha soluble N-ethylmaleimide-sensitive fusion protein (α-SNAP) and serine hydroxymethyltransferase (SHMT). In contrast, other defense genes are not directly transcriptionally activated by harpin. The results indicate harpin induces pathogen associated molecular pattern (PAMP) triggered immunity (PTI) and effector-triggered immunity (ETI) defense processes in the root, activating defense to parasitic nematodes.


Sujet(s)
Protéines d'Arabidopsis , Arabidopsis , Gossypium , Nematoda , Maladies des plantes , Transduction du signal , Animaux , Arabidopsis/génétique , Arabidopsis/immunologie , Arabidopsis/parasitologie , Protéines d'Arabidopsis/génétique , Protéines d'Arabidopsis/immunologie , Gossypium/génétique , Gossypium/immunologie , Gossypium/parasitologie , Maladies des plantes/génétique , Maladies des plantes/immunologie , Maladies des plantes/parasitologie , Transduction du signal/génétique , Transduction du signal/immunologie
12.
Plant Physiol Biochem ; 114: 60-71, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28273511

RÉSUMÉ

A Glycine max homolog of the Arabidopsis thaliana NON-RACE SPECIFIC DISEASE RESISTANCE 1 (NDR1) coiled-coil nucleotide binding leucine rich repeat (CC-NB-LRR) defense signaling gene (Gm-NDR1-1) is expressed in root cells undergoing a defense response to the root pathogenic nematode, Heterodera glycines. Gm-NDR1-1 overexpression in the H. glycines-susceptible genotype G. max[Williams 82/PI 518671] impairs parasitism. In contrast, Gm-NDR1-1 RNA interference (RNAi) in the H. glycines-resistant genotype G. max[Peking/PI 548402] facilitates parasitism. The broad effectiveness of Gm-NDR1-1 in impairing parasitism has then been examined by engineering its heterologous expression in Gossypium hirsutum which is susceptible to the root pathogenic nematode Meloidogyne incognita. The heterologous expression of Gm-NDR1-1 in G. hirsutum effectively impairs M. incognita parasitism, reducing gall, egg mass, egg and juvenile numbers. In contrast to our prior experiments examining the effectiveness of the heterologous expression of a G. max homolog of the A. thaliana salicyclic acid signaling (SA) gene NONEXPRESSOR OF PR1 (Gm-NPR1-2), no cumulative negative effect on M. incognita parasitism has been observed in G. hirsutum expressing Gm-NDR1-1. The results indicate a common genetic basis exists for plant resistance to parasitic nematodes that involves Gm-NDR1. However, the Gm-NDR1-1 functions in ways that are measurably dissimilar to Gm-NPR1-2. Notably, Gm-NDR1-1 overexpression leads to increased relative transcript levels of its homologs of A. thaliana genes functioning in SA signaling, including NPR1-2, TGA2-1 and LESION SIMULATING DISEASE1 (LSD1-2) that is lost in Gm-NDR1-1 RNAi lines. Similar observations have been made regarding the expression of other defense genes.


Sujet(s)
Glycine max/génétique , Glycine max/parasitologie , Protéines végétales/génétique , Animaux , Protéines d'Arabidopsis/génétique , Résistance à la maladie , Régulation de l'expression des gènes végétaux , Gossypium/génétique , Gossypium/parasitologie , Interactions hôte-parasite , Maladies des plantes/génétique , Maladies des plantes/parasitologie , Protéines végétales/métabolisme , Racines de plante/génétique , Racines de plante/parasitologie , Végétaux génétiquement modifiés , Glycine max/physiologie , Facteurs de transcription/génétique , Tylenchoidea/pathogénicité
13.
Plant Dis ; 101(5): 774-784, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-30678579

RÉSUMÉ

In the past decade, increased attention has been placed on biological control of plant-parasitic nematodes using various fungi and bacteria. The objectives of this study were to evaluate the potential of 662 plant growth-promoting rhizobacteria (PGPR) strains for mortality to Meloidogyne incognita J2 in vitro and for nematode management in greenhouse, microplot, and field trials. Results indicated that the mortality of M. incognita J2 by the PGPR strains ranged from 0 to 100% with an average of 39%. Among the PGPR strains examined, 212 of 662 strains (or 33%) caused significantly greater mortality percent of M. incognita J2 than the untreated control. Bacillus was the major genus initiating a greater mortality percentage when compared with the other genera. In subsequent trials, B. velezensis strain Bve2 reduced M. incognita eggs per gram of cotton root in the greenhouse trials at 45 days after planting (DAP) similarly to the commercial standards Abamectin and Clothianidin plus B. firmus I-1582. Bacillus mojavensis strain Bmo3, B. velezensis strain Bve2, B. subtilis subsp. subtilis strain Bsssu3, and the Mixture 2 (Abamectin + Bve2 + B. altitudinis strain Bal13) suppressed M. incognita eggs per gram of root in the microplot at 45 DAP. Bacillus velezensis strains Bve2 and Bve12 also increased seed-cotton yield in the microplot and field trials. Overall, results indicate that B. velezensis strains Bve2 and Bve12, B. mojavensis strain Bmo3, and Mixture 2 have potential to reduce M. incognita population density and to enhance growth of cotton when applied as in-furrow sprays at planting.

14.
Plant Signal Behav ; 12(2): e1274481, 2017 02.
Article de Anglais | MEDLINE | ID: mdl-28010187

RÉSUMÉ

The term regulon has been coined in the genetic model plant Arabidopsis thaliana, denoting a structural and physiological defense apparatus defined genetically through the identification of the penetration (pen) mutants. The regulon is composed partially by the soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor (SNARE) syntaxin PEN1. PEN1 has homology to a Saccharomyces cerevisae gene that regulates a Secretion (Sec) protein, Suppressor of Sec 1 (Sso1p). The regulon is also composed of the ß-glucosidase (PEN2) and an ATP binding cassette (ABC) transporter (PEN3). While important in inhibiting pathogen infection, limited observations have been made regarding the transcriptional regulation of regulon genes until now. Experiments made using the model agricultural Glycine max (soybean) have identified co-regulated gene expression of regulon components. The results explain the observation of hundreds of genes expressed specifically in the root cells undergoing the natural process of defense. Data regarding additional G. max genes functioning within the context of the regulon are presented here, including Sec 14, Sec 4 and Sec 23. Other examined G. max homologs of membrane fusion genes include an endosomal bromo domain-containing protein1 (Bro1), syntaxin6 (SYP6), SYP131, SYP71, SYP8, Bet1, coatomer epsilon (ϵ-COP), a coatomer zeta (ζ-COP) paralog and an ER to Golgi component (ERGIC) protein. Furthermore, the effectiveness of biochemical pathways that would function within the context of the regulon ave been examined, including xyloglucan xylosyltransferase (XXT), reticuline oxidase (RO) and galactinol synthase (GS). The experiments have unveiled the importance of the regulon during defense in the root and show how the deposition of callose relates to the process.


Sujet(s)
Protéines d'Arabidopsis/métabolisme , Arabidopsis/métabolisme , Transporteurs ABC/génétique , Transporteurs ABC/métabolisme , Arabidopsis/génétique , Protéines d'Arabidopsis/génétique , Galactosyltransferases/génétique , Galactosyltransferases/métabolisme , Glucanes/métabolisme , N-Glycosyl hydrolases/génétique , N-Glycosyl hydrolases/métabolisme , Oxidoreductases, (N-demethylating)/génétique , Oxidoreductases, (N-demethylating)/métabolisme , Pentosyltransferases/génétique , Pentosyltransferases/métabolisme , Racines de plante/génétique , Racines de plante/métabolisme , Régulon/génétique , Protéines SNARE/génétique , Protéines SNARE/métabolisme , Glycine max/génétique , Glycine max/métabolisme , bêta-Glucosidase/génétique , bêta-Glucosidase/métabolisme
16.
Brain Struct Funct ; 220(3): 1825-38, 2015.
Article de Anglais | MEDLINE | ID: mdl-25665801

RÉSUMÉ

The prominent tropism of tetanus toxin (TeTx) towards peripheral nerves with retrograde transport and transfer to central neurons render it an invaluable probe for exploring fundamental neuronal processes such as endocytosis, retrograde trafficking and trans-synaptic transport to central neurons. While the specificity of TeTx to nerve cells has been attributed to its binding domains (HC and HCC), molecular determinants of the long-range trafficking that ensure its central delivery and induction of spastic paralysis remain elusive. Here, we report that a protease-inactive TeTx mutant (TeTIM) fused to core streptavidin (CS) proved superior to CS-HC and CS-HCC fragments in antagonizing the internalization of the active toxin in cultured spinal cord neurons. Also, in comparison to CS-HC and CS-HCC, CS-TeTIM undergoes faster clearance from motor nerve terminals after peripheral injection, and is detected in a greater number of neurons in the spinal cord and brain stem ipsi-lateral to the administration site. Consistent with trans-synaptic transfer from motor neurons to inter-neurons, CS-TeTIM infiltrated non-cholinergic cells in the spinal cord; in contrast, the retrograde spread of CS-HC was largely restricted to neurons stained for choline acetyltransferase. Peripheral injection of CS-TeTIM conjugated to a lentivirus encoding mutated SNAP-25, resistant to cleavage by botulinum neurotoxin A, E and C1, rendered spontaneous excitatory postsynaptic currents in motor neurons resilient to challenge by type A toxin in vitro, whereas the same virus conjugated to CS-HC proved ineffective. These findings indicate that full-length inactive TeTx greatly exceeds HC and HCC in targeting and invading motor nerve terminals at the periphery and exploits more efficiently the retrograde transport and trans-synaptic transfer mechanisms of motor neurons to arrive at central neurons. Such qualities render TeTIM a more suitable research probe and neuron-targeting vehicle for retro-axonal delivery of viral vectors to the CNS.


Sujet(s)
Transport axonal/physiologie , Tronc cérébral/métabolisme , Motoneurones/métabolisme , Moelle spinale/métabolisme , Synapses/métabolisme , Toxine tétanique/métabolisme , Animaux , Transport axonal/effets des médicaments et des substances chimiques , Tronc cérébral/effets des médicaments et des substances chimiques , Tronc cérébral/physiologie , Cellules cultivées , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Motoneurones/cytologie , Motoneurones/effets des médicaments et des substances chimiques , Motoneurones/physiologie , Rats , Moelle spinale/cytologie , Moelle spinale/effets des médicaments et des substances chimiques , Synapses/effets des médicaments et des substances chimiques , Protéine SNAP-25/métabolisme , Toxine tétanique/pharmacologie
17.
Plant Signal Behav ; 10(1): e977737, 2015.
Article de Anglais | MEDLINE | ID: mdl-25530246

RÉSUMÉ

Experiments show the membrane fusion genes α soluble NSF attachment protein (α-SNAP) and syntaxin 31 (Gm-SYP38) contribute to the ability of Glycine max to defend itself from infection by the plant parasitic nematode Heterodera glycines. Accompanying their expression is the transcriptional activation of the defense genes ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1) and NONEXPRESSOR OF PR1 (NPR1) that function in salicylic acid (SA) signaling. These results implicate the added involvement of the antiapoptotic, environmental response gene LESION SIMULATING DISEASE1 (LSD1) in defense. Roots engineered to overexpress the G. max defense genes Gm-α-SNAP, SYP38, EDS1, NPR1, BOTRYTIS INDUCED KINASE1 (BIK1) and xyloglucan endotransglycosylase/hydrolase (XTH) in the susceptible genotype G. max[Williams 82/PI 518671] have induced Gm-LSD1 (Gm-LSD1-2) transcriptional activity. In reciprocal experiments, roots engineered to overexpress Gm-LSD1-2 in the susceptible genotype G. max[Williams 82/PI 518671] have induced levels of SYP38, EDS1, NPR1, BIK1 and XTH, but not α-SNAP prior to infection. In tests examining the role of Gm-LSD1-2 in defense, its overexpression results in ∼52 to 68% reduction in nematode parasitism. In contrast, RNA interference (RNAi) of Gm-LSD1-2 in the resistant genotype G. max[Peking/PI 548402] results in an 3.24-10.42 fold increased ability of H. glycines to parasitize. The results identify that Gm-LSD1-2 functions in the defense response of G. max to H. glycines parasitism. It is proposed that LSD1, as an antiapoptotic protein, may establish an environment whereby the protected, living plant cell could secrete materials in the vicinity of the parasitizing nematode to disarm it. After the targeted incapacitation of the nematode the parasitized cell succumbs to its targeted demise as the infected root region is becoming fortified.


Sujet(s)
Glycine max/génétique , Glycine max/parasitologie , Protéines végétales/métabolisme , Racines de plante/parasitologie , Protéines Qa-SNARE/métabolisme , Tylenchida/immunologie , Animaux , Régulation de l'expression des gènes végétaux/physiologie , Génotype , Protéines végétales/génétique , Protéines Qa-SNARE/génétique , Transduction du signal , Protéines SNAP/génétique , Protéines SNAP/métabolisme , Glycine max/immunologie , Glycine max/métabolisme
18.
Neurourol Urodyn ; 33 Suppl 3: S14-20, 2014 Jul.
Article de Anglais | MEDLINE | ID: mdl-25042137

RÉSUMÉ

The utility of botulinum neurotoxin type A (BoNT/A) for treating overactive muscles and endocrine glands is attributable to a unique conflation of properties honed to exploit and inactivate synaptic transmission. Specific, high-affinity coincident binding to gangliosides plus an intraluminal loop of synaptic vesicle protein 2 (SV2) by the heavy chain (HC) of BoNT/A confers selectivity for presynaptic nerve terminals and subsequent uptake by endocytosis. Upon vesicle acidification, the HC forms a channel for transmembrane transfer of the light chain to the cytosol, as observed by single channel recordings. The light chain is a Zn(2+) -dependent endoprotease that cleaves and inactivates SNAP-25, thereby blocking exocytotic release of transmitters, a discovery that revealed the pivotal role of the latter in synaptic vesicle fusion. A di-leucine motif in BoNT/A light chain stabilizes this protease, contributing to its longevity inside nerves. The ubiquity of SV2 and SNAP-25 has prompted re-evaluation of the nerve types susceptible to BoNT/A. In urology, there is emerging evidence that BoNT/A blocks neuropeptide release from afferent nerves, exocytosis of acetylcholine and purines from efferent nerves, and possibly ATP release from the urothelium. Suppression by BoNT/A of the surface expression of nociceptor channels on bladder afferents might also contribute to its improvement of urological sensory symptoms.


Sujet(s)
Toxines botuliniques de type A/usage thérapeutique , Agents neuromusculaires/usage thérapeutique , Terminaisons présynaptiques/effets des médicaments et des substances chimiques , Vessie neurologique/traitement médicamenteux , Vessie hyperactive/traitement médicamenteux , Vessie urinaire/effets des médicaments et des substances chimiques , Vessie urinaire/innervation , Animaux , Toxines botuliniques de type A/effets indésirables , Voies efférentes/effets des médicaments et des substances chimiques , Voies efférentes/métabolisme , Voies efférentes/physiopathologie , Endocytose/effets des médicaments et des substances chimiques , Exocytose/effets des médicaments et des substances chimiques , Humains , Agents neuromusculaires/effets indésirables , Terminaisons présynaptiques/métabolisme , Transmission synaptique/effets des médicaments et des substances chimiques , Résultat thérapeutique , Vessie neurologique/diagnostic , Vessie neurologique/métabolisme , Vessie neurologique/physiopathologie , Vessie hyperactive/diagnostic , Vessie hyperactive/métabolisme , Vessie hyperactive/physiopathologie
19.
FEBS J ; 281(14): 3243-60, 2014 Jul.
Article de Anglais | MEDLINE | ID: mdl-24863955

RÉSUMÉ

Sympathetic neurons ramify to innervate multiple cells in target tissues. In compartmentalized cultures of rat superior cervical ganglion neurons, cleavage of synaptosomal-associated protein of Mr  = 25 000 (SNAP-25) in neurites exposed to botulinum neurotoxin type A (BoNT/A) arrested their growth and collapsed interstitial branches, but this required large, nonclinical doses. A protease-inactive mutant proved ineffective, confirming involvement of SNAP-25 in neurite extension and arborization. BoNT/C1 acted like BoNT/A, but BoNT/E caused only mild inhibition, likely due to transient SNAP-25 proteolysis. Near-total lack of susceptibility to BoNT/B or BoNT/D revealed that vesicle-associated membrane protein (VAMPs) isoforms 1-3 are not essential. Neurite length was not reduced when either BoNT/A or BoNT/C1 was applied to the somata, with no detrimental effect on neuron viability being observed. Treatments that protect cells from deprivation of nerve growth factor failed to prevent the toxin-induced loss of neurites. Inactivation of SNAP-25 caused the accumulation at neurite branch sites of Golgi-derived organelles labelled with N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-sphingosine conjugated to bovine serum albumin, prior to the collapse of arbors. Notably, neurite growth was ~ 1000-fold less susceptible to BoNT/A than cholinergic transmission in these neurons. Accordingly, a BoNT/A acceptor synaptic vesicle protein 2 (SV2) was found to be colocalized with VAMP 1-3, but not with VAMP 7, which is implicated in the growth of neurites. In conclusion, neurites depend on SNAP-25 for extension but this is quite resistant to BoNT/A, possibly, because of a low density of SV2 at growth sites that are distant from the highly susceptible regions of neurotransmitter release.


Sujet(s)
Appareil de Golgi/physiologie , Neurites/physiologie , Neurones/physiologie , Animaux , Toxines botuliniques/métabolisme , Toxines botuliniques de type A , Cellules cultivées , Appareil de Golgi/métabolisme , Glycoprotéines membranaires/métabolisme , Protéines de tissu nerveux/métabolisme , Neurites/métabolisme , Neurones/cytologie , Rats , Ganglion cervical supérieur/cytologie , Transmission synaptique , Protéine SNAP-25/physiologie
20.
PLoS One ; 9(2): e89887, 2014.
Article de Anglais | MEDLINE | ID: mdl-24587100

RÉSUMÉ

A quantitative PCR procedure targeting the Heterodera glycines ortholog of the Caenorhabditis elegans uncoordinated-78 gene was developed. The procedure estimated the quantity of H. glycines from metagenomic DNA samples isolated directly from field soil under agronomic production. The estimation of H. glycines quantity was determined in soil samples having other soil dwelling plant parasitic nematodes including Hoplolaimus, predatory nematodes including Mononchus, free-living nematodes and biomass. The methodology provides a framework for molecular diagnostics of nematodes from metagenomic DNA isolated directly from field soil.


Sujet(s)
Métagénome/génétique , Sol/composition chimique , Sol/parasitologie , Tylenchoidea/génétique , Animaux , Séquence nucléotidique , Protéines de Caenorhabditis elegans/génétique , Amorces ADN/génétique , Protéines des microfilaments/génétique , Données de séquences moléculaires , Réaction de polymérisation en chaîne , Analyse de séquence d'ADN , Spécificité d'espèce
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE